Company intelligence / Profile preview

Roseway Labs

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

Roseway Labs is an active UK-based compounding pharmacy founded in 2018. It provides bespoke compounded medications, licensed/unlicensed medicines, vitamins, supplements, and diagnostic kits to private doctors and patients. The company specializes in hormones, thyroid health, dermatology, hair loss treatments, gut health solutions including Lyme disease support and low-dose naltrexone. It operates an innovative e-prescribing system for the private market. No clinical trial results are published as it does not develop proprietary drugs.

Therapeutic areas: GastroenterologyEndocrinologyDermatology
Modalities: Small moleculeHormoneVitamin/supplement
Industry: Non-Academic Healthcare

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Roseway Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Roseway Labs.

Explore the full profile